Vascular Imaging Market Size & Forecast 2025–2033

Ultrasound Technique Dominance in the Vascular Imaging Market

Among the five principal imaging techniques—magnetic resonance imaging, ultrasound, computed tomography, nuclear imaging, and X-ray—ultrasound has established itself as the dominant modality in the Vascular Imaging Market, commanding the largest revenue share and continuing to consolidate its position across multiple care settings. Its primacy is rooted in a unique combination of clinical utility, cost-effectiveness, real-time imaging capability, and the absence of ionizing radiation, making it universally applicable across patient demographics including pediatric, pregnant, and renally impaired populations.

Vascular ultrasound procedures encompass duplex ultrasonography, Doppler flow imaging, and intravascular ultrasound (IVUS), each addressing distinct diagnostic and procedural guidance needs. Duplex ultrasonography—combining B-mode anatomical imaging with color-flow Doppler—is the standard of care for carotid artery stenosis assessment, deep vein thrombosis (DVT) screening, abdominal aortic aneurysm (AAA) surveillance, and peripheral arterial disease evaluation. The modality's portability and real-time feedback make it indispensable in emergency departments, intensive care units, and increasingly in ambulatory and community clinic settings.

The global installed base of vascular ultrasound systems is substantial, and replacement cycles are accelerating as healthcare systems upgrade to systems with enhanced spatial resolution, contrast-enhanced ultrasound (CEUS) capability, and integrated AI-assisted measurement tools. CEUS, in particular, is gaining regulatory traction in Europe and North America for endovascular leak detection and renal artery assessment, expanding ultrasound's clinical footprint into indications previously dominated by CTA and MRA.

From a competitive standpoint, several major players have invested heavily in premium vascular ultrasound platforms. GE Healthcare has advanced its LOGIQ and Vivid series with AI-powered vascular quantification modules. Koninklijke Philips N.V. continues to evolve its EPIQ and Affiniti ultrasound lines with integrated workflow automation for vascular studies. Samsung Medison has expanded aggressively in the mid-tier segment with its RS and V-Scan lines, targeting emerging markets where cost sensitivity constrains premium system adoption. Esaote SPA, a dedicated ultrasound specialist, maintains a strong vascular-focused portfolio with the MyLab series, which is well-regarded in European vascular surgery and radiology departments.

Geographically, ultrasound's dominance is most pronounced in Asia Pacific, where lower per-procedure costs and high patient throughput demands favor the modality. In North America and Europe, while CTA and MRA are frequently preferred for complex vascular mapping prior to surgical or endovascular intervention, ultrasound retains primacy for first-line assessment and surveillance protocols.

The segment's growth is further reinforced by the proliferation of handheld and pocket-sized ultrasound devices from companies including Butterfly Network and Fujifilm Corporation's Sonosite division, which are extending point-of-care vascular assessment capabilities to general practitioners, emergency physicians, and vascular nurses. This democratization of ultrasound access is not only growing the addressable market but is also compressing the time-to-diagnosis cycle, which is particularly impactful in acute DVT and arterial occlusion presentations where time-sensitive clinical decisions are critical.

Overall, ultrasound's share within the Vascular Imaging Market is expected to remain dominant through 2033, with the segment growing faster than the nuclear imaging and conventional X-ray sub-segments, and at a pace broadly aligned with the overall market CAGR of 7.8%, supported by continuous technological evolution and expanding procedural indications.

Key Market Drivers and Constraints Shaping the Vascular Imaging Market

The Vascular Imaging Market is propelled by several quantifiable drivers, while facing a distinct set of structural constraints that modulate its growth trajectory.

Driver 1 — Rising Cardiovascular Disease Prevalence: Cardiovascular disease accounts for approximately 32% of all global deaths annually, creating an unrelenting demand for vascular diagnostic procedures. The Global Burden of Disease study estimates that ischemic heart disease and stroke collectively affect over 500 million people worldwide, directly expanding the procedural volume addressable by vascular imaging technologies. PAD alone affects an estimated 236 million adults globally, representing a major screening opportunity.

Driver 2 — Aging Demographics: Populations aged 65 and above are the fastest-growing demographic cohort across all high-income markets. In the United States, this cohort is projected to reach 80 million by 2040, nearly double the 2020 figure. Given that vascular disease risk escalates sharply with age, demographic aging functions as a structural tailwind for imaging procedure volumes independent of technological or policy factors.

Driver 3 — AI and Software Integration: AI-enabled image analysis platforms are reducing radiologist interpretation time by an estimated 30–50% per study in validated clinical deployments, improving workflow efficiency and enabling imaging centers to handle higher procedural throughput without proportional increases in specialist staffing.

Driver 4 — Expanding Healthcare Infrastructure in Emerging Markets: Capital expenditure on diagnostic imaging equipment in Asia Pacific and Middle East & Africa regions is growing at double-digit rates, supported by government-funded hospital construction programs and multilateral development bank financing.

Constraint 1 — High Equipment and Operational Costs: Advanced CTA and MRA systems carry capital costs ranging from $500,000 to over $3 million per unit, creating significant procurement barriers for community hospitals and clinics in lower-income markets, limiting market penetration depth.

Constraint 2 — Skilled Workforce Shortage: The global shortage of trained vascular radiologists and sonographers constrains procedural capacity even in markets with adequate imaging hardware. This bottleneck is particularly acute in sub-Saharan Africa and parts of Southeast Asia, where radiologist-to-population ratios remain critically low.

Constraint 3 — Reimbursement Uncertainty: Variable and often restrictive reimbursement policies across payer systems in the United States, EU member states, and emerging economies create revenue predictability challenges for both equipment manufacturers and imaging service providers.

Competitive Ecosystem of the Vascular Imaging Market

The Vascular Imaging Market is characterized by a concentrated competitive landscape dominated by diversified medical technology conglomerates, with a secondary tier of specialized imaging companies. Below is a strategic profile of the principal participants:

• GE Healthcare: One of the largest imaging equipment manufacturers globally, GE Healthcare maintains a comprehensive vascular imaging portfolio spanning MR angiography, CTA, and advanced ultrasound platforms, with ongoing investment in AI-integrated imaging software through its Edison platform ecosystem.

• Koninklijke Philips N.V.: Philips operates a fully integrated vascular imaging and intervention business, combining diagnostic ultrasound, interventional X-ray, and image-guided therapy platforms, with strategic emphasis on connected care solutions and remote imaging diagnostics.

• Siemens AG: Through its Siemens Healthineers division, Siemens AG offers the SOMATOM CTA series, MAGNETOM MR systems, and ACUSON ultrasound platforms, positioning itself as a technology leader in AI-powered quantitative vascular analysis and workflow automation.

• Toshiba Corporation: Operating its medical imaging business through Canon Medical Systems (following divestiture), Toshiba Corporation's legacy vascular imaging platform portfolio includes Aquilion CTA systems and Vantage MRI systems with dedicated vascular imaging sequences and advanced post-processing capabilities.

• Fujifilm Corporation: Fujifilm Corporation has expanded its vascular imaging presence through the Sonosite point-of-care ultrasound brand and digital radiography solutions, targeting emergency and perioperative vascular assessment workflows.

• Hitachi Medical Corporation: Hitachi Medical Corporation focuses on open-architecture MRI and ultrasound platforms, with particular strength in musculoskeletal and vascular MR imaging in markets prioritizing patient comfort and accessibility.

• Samsung Medison: Samsung Medison competes aggressively in the premium and mid-tier ultrasound segments with AI-powered vascular imaging features on its RS and V7 platforms, targeting both established and emerging market hospital networks.

• Esaote SPA: Esaote SPA is a dedicated ultrasound and dedicated MRI specialist with deep expertise in vascular ultrasonography, serving European vascular surgery, angiology, and radiology departments with the MyLab series.

• Shimadzu Medical Systems: Shimadzu Medical Systems provides X-ray angiography and fluoroscopy systems for vascular interventional procedures, with a strong presence in the Asia Pacific market, particularly in Japan and Southeast Asia.

• Carestream Health Inc.: Carestream Health Inc. offers digital radiography and healthcare IT solutions that support vascular imaging workflows, with emphasis on image management, archiving, and enterprise-level PACS integration.

• Hologic Inc.: Hologic Inc. primarily targets women's health imaging but maintains relevance in vascular-adjacent applications through its interventional and biopsy guidance technologies.

• Abbott Laboratories: Abbott Laboratories contributes to the vascular imaging ecosystem through its intravascular imaging and coronary physiology assessment portfolio, including IVUS and optical coherence tomography (OCT) catheter-based systems.

• Terumo Corporation: Terumo Corporation provides catheter-based intravascular imaging solutions and vascular intervention consumables, supporting diagnostic and therapeutic vascular procedures across interventional cardiology and peripheral vascular surgery.

Recent Developments & Milestones in the Vascular Imaging Market

• January 2025: GE Healthcare announced the commercial launch of an AI-powered vascular segmentation module embedded within its LOGIQ E10s ultrasound platform, enabling automated carotid intima-media thickness (cIMT) quantification with reported inter-observer variability reduction of 40% versus manual assessment.

• March 2025: Siemens Healthineers received CE Mark approval for its SOMATOM Pro.Pulse CT system featuring spectral CTA capabilities optimized for peripheral vascular disease assessment, expanding its regulatory footprint in European vascular radiology departments.

• May 2025: Koninklijke Philips N.V. entered into a strategic partnership with a major U.S. health system to deploy a cloud-native vascular imaging analytics platform across 12 hospital campuses, integrating real-time AI diagnostic support for emergency vascular presentations.

• July 2024: Abbott Laboratories received FDA 510(k) clearance for an updated generation of its Ultreon optical coherence tomography (OCT) imaging catheter, improving coronary vascular visualization resolution and enabling automated plaque characterization.

• September 2024: Terumo Corporation announced a joint development agreement with a leading Japanese university hospital to co-develop next-generation intravascular ultrasound (IVUS) catheters incorporating photoacoustic imaging capabilities for enhanced lipid pool detection.

• November 2024: Fujifilm Corporation expanded its Sonosite point-of-care ultrasound distribution network across eight new Southeast Asian markets, targeting emergency medicine and community vascular screening applications.

• February 2025: The U.S. Centers for Medicare & Medicaid Services (CMS) finalized updated reimbursement codes for contrast-enhanced vascular ultrasound (CEUS) procedures, with a reimbursement rate increase of approximately 12%, accelerating clinical adoption in outpatient vascular centers.

Regional Market Breakdown for the Vascular Imaging Market

The Vascular Imaging Market exhibits distinct regional dynamics driven by healthcare infrastructure maturity, disease burden, regulatory frameworks, and capital investment capacity.

North America is the most mature and highest-revenue regional market, accounting for an estimated 38–40% of global Vascular Imaging Market revenue in 2025. The United States anchors this dominance, supported by high procedural volumes, robust private and public reimbursement coverage, and dense concentration of academic medical centers and specialized vascular programs. The regional market is growing at an estimated CAGR of 6.5–7.0%, modestly below the global average, reflecting market maturity and slower volume growth relative to emerging regions. Canada and Mexico contribute incrementally, with the latter emerging as a growth market driven by expanding private hospital networks.

Europe represents the second-largest regional market, with Germany, the United Kingdom, France, and Italy collectively accounting for the majority of European revenue. The region benefits from universal healthcare coverage models that support high imaging utilization rates and structured population-level cardiovascular screening programs. Europe's CAGR is estimated at 6.8–7.2%, with Eastern European markets growing faster as healthcare infrastructure investment accelerates under EU cohesion fund programs.

Asia Pacific is the fastest-growing region in the Vascular Imaging Market, with a projected regional CAGR of 9.5–10.5% through 2033. China and India are the primary growth engines, driven by rapidly expanding hospital networks, government health insurance scheme expansions (such as China's National Health Commission modernization initiatives and India's Ayushman Bharat program), and growing middle-class demand for advanced diagnostics. Japan and South Korea represent mature sub-markets within the region, characterized by high technology adoption and strong domestic medical device manufacturing ecosystems. ASEAN markets including Indonesia, Vietnam, and Thailand are emerging as high-growth secondary clusters.

Middle East & Africa is a heterogeneous region with high-growth pockets concentrated in Gulf Cooperation Council (GCC) states, where sovereign wealth fund-backed healthcare city projects and premium hospital developments are driving significant capital equipment procurement. North Africa and sub-Saharan Africa remain constrained by infrastructure gaps and budget limitations, though international development financing is gradually improving access.

South America, led by Brazil and Argentina, is a moderate-growth market with a regional CAGR estimated at **7.0–7.5

Vascular Imaging Market Segmentation

• 1. Technique
  • 1.1. Magnetic Resonance Imaging
  • 1.2. Ultrasound
  • 1.3. Computed Tomography
  • 1.4. Nuclear Imaging
  • 1.5. X-Ray
• 2. Procedure
  • 2.1. Coronary Angiography
  • 2.2. Peripheral Angiography
  • 2.3. Neurovascular Angiography
  • 2.4. Vascular Ultrasound Procedures
  • 2.5. Micro Angiography
  • 2.6. Other Procedures
• 3. End User
  • 3.1. Hospitals
  • 3.2. Diagnostic Imaging Centers
  • 3.3. Other End Users

Vascular Imaging Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific